InsiderTrades

Form 4 for BEAM Beam Therapeutics Inc.

Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-22 · accession 0000899243-21-049634 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-12-23 2021-12-22 BEAM Ciaramella Giuseppe Pres, CSO S - Sale+OE $86.13 -2,607 63.1K -4% -$224.5K
D 2021-12-23 2021-12-22 BEAM Ciaramella Giuseppe Pres, CSO M - OptEx $7.22 +2,607 65.4K +4% +$18.8K
D 2021-12-23 2021-12-22 BEAM Ciaramella Giuseppe Pres, CSO M - OptEx $0.00 -2,607 89.6K -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-22 S D 1,216 $85.39 64,164 D — — (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.00 to $85.88, inclusive.
2 Common Common Stock 2021-12-22 S D 290 $87.34 62,773 D — —
3 Common Common Stock 2021-12-22 S D 1,101 $86.62 63,063 D — — (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.15 to $86.99, inclusive.
4 Common Common Stock 2021-12-22 M A 2,607 $7.22 65,380 D — —
5 Derivative Stock Option (Right to Buy) 2021-12-22 M D 2,607 $0.00 89,646 D $7.22 · — to 2029-05-17 2,607 Common Stock (F5) The option vests as to 25% on the first anniversary of the of the vesting commencement date, October 1, 2019, and at a rate of 2.78% each month thereafter until the option is fully vested.